Pathological effect of mycophenolate mofetil(MMF) and glucocorticoid on active and chronic lesions in diffuse proliferative lupus nephritis

丁磊,赵明辉,邹万忠,刘玉春,王海燕

DOI: https://doi.org/10.3760/j.issn:1001-7097.2002.01.002

2002-01-01

Abstract:Objective To investigate the histopathologic alterations and the mechanisms of MMF combined glucocorticoid therapy in diffuse proliferative lupus nephritis(DPLN) Methods Nine patients with DPLN received re-biopsy after MMF and prednisone treatment for 6-7 months. T lymphocyte, monocyte/macrophage, proliferative cells, osteopontin(OPN), fibrinectin (EN), a-smooth muscle actin (αa-SMA), and TGF-β1 were detected by immunohistochemistry of SP method. Collagens were stained with Sirus red. Cells were counted and color image analytical system was applied to quantitate the staining. AI (active index) and CI (chronic index) were scored. The changes of above indicators were assessed and their correlations were analyzed. Results (1) After treatment, Al score decreased, T cells, monocytes/ macrophages infiltration, OPN expression and the percentage of proliferative cells in glomerulus and tubulointerstitium decreased significantly. (2) CL score didn‘t decrease significantly after treatment, the FN area ratio in glomerulus and tubulointerstitium, the collagen area ratio in tubulointerstitium and the expression of α-SMA and TGF-β1 were not reduced significantly. After treatment, inflammatory cell infiltration was correlated positively with the expression of EN. α-SMA and collagens in interstitium. Conclusions The active inflammatory lesions can be ameliorated through reduction of lymphocytes and monocytes/macrophages infiltration, inhibition of cell proliferation and down regulation of adhesion molecules. However, the chronic fibrotic lesions can not be reduced significantly.